These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 11290597)
1. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Newman DK; Hamilton C; Newman PJ Blood; 2001 Apr; 97(8):2351-7. PubMed ID: 11290597 [TBL] [Abstract][Full Text] [Related]
2. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. Henshall TL; Jones KL; Wilkinson R; Jackson DE J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261 [TBL] [Abstract][Full Text] [Related]
3. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. Jackson DE; Kupcho KR; Newman PJ J Biol Chem; 1997 Oct; 272(40):24868-75. PubMed ID: 9312087 [TBL] [Abstract][Full Text] [Related]
4. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation. Su MW; Yu CL; Burakoff SJ; Jin YJ J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643 [TBL] [Abstract][Full Text] [Related]
8. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. Newton-Nash DK; Newman PJ J Immunol; 1999 Jul; 163(2):682-8. PubMed ID: 10395658 [TBL] [Abstract][Full Text] [Related]
9. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31). Sagawa K; Kimura T; Swieter M; Siraganian RP J Biol Chem; 1997 Dec; 272(49):31086-91. PubMed ID: 9388260 [TBL] [Abstract][Full Text] [Related]
10. Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31. Pumphrey NJ; Taylor V; Freeman S; Douglas MR; Bradfield PF; Young SP; Lord JM; Wakelam MJ; Bird IN; Salmon M; Buckley CD FEBS Lett; 1999 Apr; 450(1-2):77-83. PubMed ID: 10350061 [TBL] [Abstract][Full Text] [Related]
11. Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a. DeBell KE; Simhadri VR; Mariano JL; Borrego F BMC Immunol; 2012 Apr; 13():23. PubMed ID: 22537350 [TBL] [Abstract][Full Text] [Related]
12. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1. Tourdot BE; Brenner MK; Keough KC; Holyst T; Newman PJ; Newman DK Biochemistry; 2013 Apr; 52(15):2597-608. PubMed ID: 23418871 [TBL] [Abstract][Full Text] [Related]
13. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets. Cicmil M; Thomas JM; Leduc M; Bon C; Gibbins JM Blood; 2002 Jan; 99(1):137-44. PubMed ID: 11756163 [TBL] [Abstract][Full Text] [Related]
14. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. Frearson JA; Alexander DR J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634 [TBL] [Abstract][Full Text] [Related]
15. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions. Nakamura K; Brauweiler A; Cambier JC J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804 [TBL] [Abstract][Full Text] [Related]
16. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006 [TBL] [Abstract][Full Text] [Related]
17. Construction and expression of an enzymatically active form of PECAM-1 containing the phosphatase domain of the protein tyrosine phosphatase, SHP-2. Noda M; Paddock C; Newman PJ Protein Expr Purif; 2001 Jun; 22(1):113-9. PubMed ID: 11388808 [TBL] [Abstract][Full Text] [Related]
18. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. Bruhns P; Marchetti P; Fridman WH; Vivier E; Daƫron M J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767 [TBL] [Abstract][Full Text] [Related]
19. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385 [TBL] [Abstract][Full Text] [Related]
20. Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2. Barrow AD; Astoul E; Floto A; Brooke G; Relou IA; Jennings NS; Smith KG; Ouwehand W; Farndale RW; Alexander DR; Trowsdale J J Immunol; 2004 May; 172(10):5838-42. PubMed ID: 15128762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]